Zhang Ai-Hong, Liu Guo-Qing
Institute of Cardiovascular Sciences, Peking University, Beijing 100083.
Sheng Li Ke Xue Jin Zhan. 2004 Apr;35(2):125-9.
Post-transcriptional gene silencing (PTGS) initiated by dsRNA, which result in specific degradation of homologous mRNA, is called RNAi. The discovery of RNAi greatly intrigued researchers, and was followed by a flood of papers that described the phenomenon and mechanism of RNAi. More excitingly, RNAi has recently been developed into a new tool, showing promising role in reverse genetics, gene therapy and anti-viral infection. This review provides the progress of the application of RNAi technology in mammalian animals.
由双链RNA引发的导致同源mRNA特异性降解的转录后基因沉默(PTGS)被称为RNA干扰(RNAi)。RNAi的发现极大地激发了研究人员的兴趣,随后涌现出大量描述RNAi现象和机制的论文。更令人兴奋的是,RNAi最近已发展成为一种新工具,在反向遗传学、基因治疗和抗病毒感染方面显示出广阔的应用前景。本文综述了RNAi技术在哺乳动物中的应用进展。